Survival After Development of Contralateral Breast Cancer in Korean Patients With Breast Cancer.

ABSTRACT:

Importance

Contralateral breast cancer (CBC) is the most frequently diagnosed primary cancer in patients with breast cancer. Although many studies have reported survival after the development of CBC, results have been inconsistent.

Objective

To investigate whether the development of CBC is associated with survival among patients with breast cancer.

Design, setting, and participants

This cohort study was conducted at the Asan Medical Center, Korea, among patients who were diagnosed with primary unilateral, nonmetastatic, stage 0 to III breast cancer between 1999 and 2013 and followed up through 2018. The median (IQR) follow-up was 107 (75-143) months. Patients were categorized into CBC and no-CBC groups by whether they developed CBC during the follow-up period. Data we

SUBMITTER: Kim H 

PROVIDER: S-EPMC10502526 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature